NQSE:XETRA:XETRA-iShares NASDAQ 100 UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 11.254

Change

+0.01 (+0.05)%

Market Cap

USD 0.35B

Volume

0.06M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.13 (+0.26%)

USD 473.61B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.10 (+0.62%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.20 (+0.77%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.20 (+0.74%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.07 (+0.28%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

+1.30 (+0.80%)

USD 126.93B
JARI:XETRA Amundi Index Solutions - Amund..

+0.30 (+0.69%)

USD 101.50B
8R80:XETRA Amundi Index Solutions - Amund..

+0.16 (+0.11%)

USD 99.29B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.31 (+0.63%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+3.08 (+0.58%)

USD 80.38B

ETFs Containing NQSE:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.95% 62% D 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.95% 62% D 62% D
Trailing 12 Months  
Capital Gain 32.81% 90% A- 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 32.81% 90% A- 88% B+
Trailing 5 Years  
Capital Gain 132.86% 98% N/A 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 132.86% 98% N/A 94% A
Average Annual (5 Year Horizon)  
Capital Gain 19.77% 93% A 90% A-
Dividend Return 19.77% 93% A 90% A-
Total Return N/A 66% D+ 55% F
Risk Return Profile  
Volatility (Standard Deviation) 27.03% 13% F 24% F
Risk Adjusted Return 73.14% 88% B+ 89% A-
Market Capitalization 0.35B 60% D- 54% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.